Letters sent to healthcare professionals in June 2015

Last month, letters sent included one for the oral anticoagulant edoxaban.

In each issue of Drug Safety Update we summarise drug safety letters sent to healthcare professionals that are not linked to their own Drug Safety Update article. In June 2015, letters sent included one for the oral anticoagulant edoxaban.

Article citation: Drug Safety Update volume 8 issue 12 July 2015: 4.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.